These results elucidate the synergistic roles of hydrogen bonding, hydrophobic packing, and conformational adaptability in MAT2A inhibition, providing a structural foundation for designing selective therapeutics against MTAP-deleted cancers. The gene discussed is MTAP; the disease is cancer.